Clinical Trial Update: TPF Induction With Concomitant Chemoradiation to Treat Patients With Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TPF induction chemotherapy with concomitant chemoradiation for head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Head and Neck Cancer | Phase 2 | Status: UNKNOWN